Abstract
The objective of the study was to analyze retrospectively the clinical, laboratory and imaging findings of multiple sclerosis (MS), such as the manifestations in a cohort of 132 patients referred to the neurology in and outpatient clinic. The proposed clinical and laboratory diagnostic criteria for MS and connective tissue disorders were systematically assessed in 132 consecutive patients. Cerebrospinal fluid serology and brain or spinal cord MRI were studied in all cases. In patients suspected for connective tissue disorder, schirmer test, rose bengal staining and biopsy of minor salivary glands were performed. A total of 115 (87%) patients were diagnosed to have definite MS, while 17 (13%) were diagnosed to have connective tissue disorder. Positive neurological and MRI findings were observed in both groups. The majority of patients with connective tissue disorder demonstrated extra-neurological manifestations like Raynaud’s phenomenon, arthritis, livedo reticularis, purpura and presence of multiple autoantibodies in their sera. All patients with MS should be screened systematically for connective tissue disorder. In the absence of pathognomonic clinical and laboratory findings, the diagnosis of MS is a diagnosis of exclusion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127
Allen IV, Millar JH, Kirk J, Shillington RK (1979) SLE clinically resembling MS and with unusual pathological and ultrastructural features. J Neurol Neurosurg Psych 42:392–401
Miro J, Pena-Sagredo JL et al (1990) Prevalence of primary SS in patients with MS. Ann Neurol 27:582–584
de Seze J, Devos D, Castelnevo G et al (2001) The prevalence of SS in patients with primary progressive MS. Neurology 57:1359–1363
Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A (2004) Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin Exp Immunol 138(1):164–170
Criswell LA, Pfeiffer KA, Lum RF et al (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGD) collection: the PTPN22 allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76(4):561–571
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277
Vitali C, Bombardieri S, Jonsson R et al (2002) European study group on classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61(6):554–558
Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42(7):1309–1311
Theodoridou A, Settas L (2006) Demyelination in rheumatic diseases. J Neurol Neurosurg Psych 77(3):290–295
Ferreira S, D’Cruz DP, Hughes GR (2006) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44(4):434–442
Reske D, Petereit HF, Heiss WD (2005) Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system: value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol Scand 112(4):207–213
Soliotis FC, Mavragani CP, Moutsopoulos HM (2006) Central nervous system involvement in Sjogren’s syndrome. Ann Rheum Dis 63(6):616–620
Morgen K, McFarland HF, Pillemer SR (2004) Central nervous system disease in primary Sjorgens syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 34(3):623–630
Delalande S, deSeze S, Fauchais AL et al (2004) Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 83(5):280–291
de Seze J, Dubucquoi S, Fauchais AL et al (2004) Autoantibodies against alpha-fodrin in Sjogren’s syndrome with neurological manifestations. J Rheumatol 31(3):500–503
Baraczka K, Nekam K, Pozsonyi T, Szuts I, Ormos G (2004) Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur J Neurol 11(1):37–42
Rovaris M, Viti B, Ciboddo G, Capra R, Filippi M (2000) Cervical cord magnetic resonance imaging findings in systemic immune-mediated diseases. J Neurol Sci 176(2):128–130
Inslicht DV, Stein AB, Pomerantz F, Ragnarsson KT (1998) Three women with lupus transverse myelitis: case reports and differential diagnosis. Arch Phys Med Rehabil 79(4):456–459
Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR (2000) Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 79(1):57–68
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pelidou, SH., Giannopoulos, S., Tzavidi, S. et al. Neurological manifestations of connective tissue diseases mimicking multiple sclerosis. Rheumatol Int 28, 15–20 (2007). https://doi.org/10.1007/s00296-007-0384-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0384-8